Spots Global Cancer Trial Database for Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma
Official Title: Consolidation Treatment With Y90-Ibritumomab Tiuxetan In Patients With High-Risk Follicular Lymphoma With Either Partial Or Complete Response To R-Chop Induction Chemotherapy
Study ID: NCT00722930
Conditions
Interventions
Study Description
Brief Summary: To evaluate the complete clinical response rate according to the International Working Group criteria with a consolidation treatment with 90Y-ibritumomab tiuxetan (Zevalin®) in patients with high-risk follicular lymphoma with either partial or complete response to R-CHOP induction chemotherapy
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hospital Virgen de la Victoria, Málaga, Malaga, Spain
Instituto Oncológico San Sebastián, Donostia, San Sebastián, Spain
Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain
Hospital Sant Joan de Reus, Reus, Tarragona, Spain
Hospital Virgen de las Nieves, Granada, , Spain
Clinia Puerta de Hierro, Madrid, , Spain
Clínica Ruber Internacional, Madrid, , Spain
Complejo Hospitalario de Pontevedra, Pontevedra, , Spain
Hospital Universitario Virgen Macarena, Sevilla, , Spain
Hospital Virgen de la Salud de Toledo, Toledo, , Spain
Hospital Universitario La Fe, Valencia, , Spain
Contact Details
Name: Mariano Provencio, MD
Affiliation: Clínica Puerta de Hierro
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
